The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Verona Pharma Plc ADR shares valued at $88,800 were purchased by EBSWORTH DAVID R on Nov 18 ’24. At $4.44 per share, EBSWORTH DAVID R acquired 20,000 shares. The insider’s holdings grew to 940,003 shares worth approximately $36.52 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, ZACCARDELLI DAVID sold 2,400 shares, netting a total of over 12,000 in proceeds. Following the sale of shares at $5.00 each, the insider now holds 15,202,352 shares.
Before that, Hahn Mark W had sold 2,400 shares from its account. In a trade valued at $12,000, the Chief Financial Officer traded Verona Pharma Plc ADR shares for $5.00 each. Upon closing the transaction, the insider’s holdings decreased to 2,400 shares, worth approximately $555.22 million.
As published in their initiating research note from Wells Fargo on October 03, 2024, Verona Pharma Plc ADR [VRNA] has been an Overweight and the price target has been revised to $50. Earlier on August 26, 2022, Piper Sandler initiated its rating. Their recommendation was “an Overweight” for VRNA stock.
Analyzing VRNA Stock Performance
During the last five days, there has been a surge of approximately 5.20%. Over the course of the year, Verona Pharma Plc ADR shares have jumped approximately 95.42%. Shares of the company reached a 52-week high of $40.13 on 11/12/24 and a 52-week low of $11.39 on 05/30/24. A 50-day SMA is recorded $33.30, while a 200-day SMA reached $21.88. Nevertheless, trading volume fell to 1.37 million shares from 1.44 million shares the previous day.
Support And Resistance Levels for Verona Pharma Plc ADR (VRNA)
According to the 24-hour chart, there is a support level at 37.86, which, if violated, would cause prices to drop to 36.88. In the upper region, resistance lies at 39.58. The next price resistance is at 40.32. RSI (Relative Strength Index) is 62.43 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.18, which suggests the price will decrease in the coming days. Percent R is at 15.00%, indicating bullish price movement. Stochastics %K at holding indicates that the stock is to be held.
Which companies own the most shares of Verona Pharma Plc ADR (VRNA)?
On September 13, 2021, H.C. Wainwright assigned a price target of “a Buy” to the stock and initiated coverage with a $25.
